| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.00097 | 1 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.00096 | 1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.00072 | 1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.00081 | 1 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00074 | 1 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.00055 | 1 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |